IVTY Invuity Inc

DEADLINE ALERT: Brower Piven Reminds Investors of the Upcoming Deadline in Class Action Lawsuit and Encourages Investors with Losses in Excess of $100,000 from Investment in Invuity, Inc. to Contact the Firm

The securities litigation law firm of Brower Piven, A Professional Corporation, announces that a class action lawsuit has been commenced in the United States District Court for the Northern District of California on behalf of purchasers of Invuity, Inc. (Nasdaq: IVTY) (“Invuity” or the “Company”) common stock during the period between July 19, 2016 and November 3, 2016, inclusive (the “Class Period”). Investors who wish to become proactively involved in the litigation have until April 28, 2017 to seek appointment as lead plaintiff.

If you wish to choose counsel to represent you and the class, you must apply to be appointed lead plaintiff and be selected by the Court. The lead plaintiff will direct the litigation and participate in important decisions including whether to accept a settlement for the class in the action. The lead plaintiff will be selected from among applicants claiming the largest loss from investment in Invuity common stock during the Class Period. Members of the class will be represented by the lead plaintiff and counsel chosen by the lead plaintiff. No class has yet been certified in the above action.

The complaint accuses the defendants of violations of the Securities Exchange Act of 1934 by virtue of the defendants’ failure to disclose during the Class Period that the continued opportunities for growth in mature active accounts stagnated after the initial sale of a new product, revenues per active account were declining, and the Company’s sales force was not meeting stated revenue growth goals in mature active accounts.

According to the complaint, following a November 3, 2016 press release and conference call announcing a dramatic cut of the Company’s revenue expectations and 2017 guidance due to lower revenue per active account, the value of Invuity shares declined significantly.

If you have suffered a loss in excess of $100,000 from investment in Invuity common stock purchased on or after July 19, 2016 and held through the revelation of negative information during and/or at the end of the Class Period and would like to learn more about this lawsuit and your ability to participate as a lead plaintiff, without cost or obligation to you, please visit our website at http://www.browerpiven.com/currentsecuritiescases.html. You may also request more information by contacting Brower Piven either by email at [email protected] or by telephone at (410) 415-6616. Brower Piven also encourages anyone with information regarding the Company’s conduct during the period in question to contact the firm, including whistleblowers, former employees, shareholders and others.

Attorneys at Brower Piven have extensive experience in litigating securities and other class action cases and have been advocating for the rights of shareholders since the 1980s. If you choose to retain counsel, you may retain Brower Piven without financial obligation or cost to you, or you may retain other counsel of your choice. You need take no action at this time to be a member of the class.

EN
20/04/2017

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Invuity Inc

 PRESS RELEASE

Invuity Announces Definitive Agreement to Be Acquired by Stryker Corpo...

Invuity Announces Definitive Agreement to Be Acquired by Stryker Corporation for $7.40 Per Share in Cash SAN FRANCISCO, Sept. 11, 2018 (GLOBE NEWSWIRE) -- Invuity, Inc. (NASDAQ: IVTY), a leading medical technology company focused on advanced surgical devices to enable better visualization, today announced it has entered into a definitive agreement with Stryker Corporation (NYSE:SYK), pursuant to which Stryker will acquire all of the outstanding shares of Invuity for $7.40 per share in cash, implying a total equity value of approximately $190 million. "The combination of Stryker's establi...

 PRESS RELEASE

Invuity Announces Commercial Launch of PhotonGuide® Adapt for Vaginal...

Invuity Announces Commercial Launch of PhotonGuide® Adapt for Vaginal Hysterectomy and Pelvic Organ Prolapse Procedures SAN FRANCISCO, Aug. 14, 2018 (GLOBE NEWSWIRE) -- Invuity, Inc. (NASDAQ:IVTY), a leading medical technology company focused on minimal access surgery, today announced the full commercial launch of PhotonGuide® Adapt, a novel system that consists of a flexible illuminator and a family of compatible retractors for surgical procedures performed vaginally including pelvic organ prolapse repairs and vaginal hysterectomies. PhotonGuide Adapt represents a new platform for Invui...

 PRESS RELEASE

Invuity Announces 2018 Second Quarter, Six-Month Financial Results

Invuity Announces 2018 Second Quarter, Six-Month Financial Results SAN FRANCISCO, Aug. 02, 2018 (GLOBE NEWSWIRE) -- (NASDAQ:IVTY), a leading medical technology company focused on minimal access surgery, today announced financial results for the second quarter and six months ended June 30, 2018. Q2 2018 Highlights Second quarter 2018 revenue grew 7.5% to $10.5 million compared to revenue of $9.8 million in the second quarter of 2017.Disposable revenue in the second quarter of 2018 grew 11.5% to $9.2 million compared to $8.3 million in the second quarter of 2017.Net loss for the second q...

 PRESS RELEASE

Invuity Announces 2018 Second Quarter Financial Results and Conference...

Invuity Announces 2018 Second Quarter Financial Results and Conference Call Date SAN FRANCISCO, July 20, 2018 (GLOBE NEWSWIRE) -- Invuity, Inc. (NASDAQ:IVTY), a leading medical technology company focused on minimal access surgery, today announced that it will release its 2018 second quarter financial results after the market closes on Thursday, August 2, 2018. In conjunction with the release, the Company will host a conference call with the investment community at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time on Thursday, August 2, 2018, to discuss the financial results and other busine...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch